Cambridge Nutritional Sciences plc Stock price

Equities

ODX

GB00B1VCP282

Medical Equipment, Supplies & Distribution

Delayed London S.E. 06:05:37 2024-03-28 am EDT 5-day change 1st Jan Change
3.5 GBX -4.11% Intraday chart for Cambridge Nutritional Sciences plc +4.48% +45.83%
Sales 2024 * 9M 11.34M Sales 2025 * - Capitalization 8.69M 10.95M
Net income 2024 * -1M -1.26M Net income 2025 * - EV / Sales 2024 * 0.5 x
Net cash position 2024 * 4.2M 5.29M Net cash position 2025 * - 0 EV / Sales 2025 * -
P/E ratio 2024 *
-7.3 x
P/E ratio 2025 *
-
Employees 91
Yield 2024 *
-
Yield 2025 *
-
Free-Float 90.83%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Cambridge Nutritional Sciences plc

1 day-4.11%
1 week+4.48%
Current month+32.08%
1 month+32.08%
3 months+45.83%
6 months+75.00%
Current year+45.83%
More quotes
1 week
3.13
Extreme 3.13
3.79
1 month
2.50
Extreme 2.5
3.79
Current year
2.30
Extreme 2.3
3.79
1 year
1.66
Extreme 1.662
3.79
3 years
1.66
Extreme 1.662
96.06
5 years
1.66
Extreme 1.662
126.95
10 years
1.66
Extreme 1.662
126.95
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 11-06-29
Members of the board TitleAgeSince
Chairman 65 21-02-10
Chief Executive Officer 54 11-06-29
Director/Board Member 53 19-02-28
More insiders
Date Price Change Volume
24-03-28 3.5 -4.11% 211 495
24-03-27 3.65 +4.29% 2,331,944
24-03-26 3.5 +6.06% 1,007,828
24-03-25 3.3 0.00% 44,211
24-03-22 3.3 -1.49% 201,932

Delayed Quote London S.E., March 28, 2024 at 06:05 am EDT

More quotes
Cambridge Nutritional Sciences plc is a United Kingdom-based specialist medical diagnostics company. The Company develops, manufactures and markets diagnostic products associated with food sensitivity and gut health. The Company serves healthcare professionals and the consumer directly with a focus on health and nutrition products.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Cambridge Nutritional Sciences plc - London S.E.